CareDx, Inc (CDNA)
NASDAQ: CDNA · Real-Time Price · USD
16.13
-0.23 (-1.41%)
May 13, 2025, 4:00 PM - Market closed
CareDx Revenue
CareDx had revenue of $84.69M in the quarter ending March 31, 2025, with 17.54% growth. This brings the company's revenue in the last twelve months to $346.42M, up 25.92% year-over-year. In the year 2024, CareDx had annual revenue of $333.79M with 19.07% growth.
Revenue (ttm)
$346.42M
Revenue Growth
+25.92%
P/S Ratio
2.50
Revenue / Employee
$532,955
Employees
650
Market Cap
898.13M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 333.79M | 53.46M | 19.07% |
Dec 31, 2023 | 280.32M | -41.47M | -12.89% |
Dec 31, 2022 | 321.79M | 25.40M | 8.57% |
Dec 31, 2021 | 296.40M | 104.20M | 54.22% |
Dec 31, 2020 | 192.19M | 65.13M | 51.25% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
CDNA News
- 15 hours ago - CareDx to Participate in Upcoming Investor Conferences - Business Wire
- 13 days ago - CareDx, Inc (CDNA) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 13 days ago - CareDx Reports First Quarter 2025 Results - Business Wire
- 15 days ago - CareDx Announces New Data on AlloSure Lung Presented at 2025 International Society for Heart and Lung Transplantation Meeting - Business Wire
- 20 days ago - CareDx Announces Presentation of 60 Abstracts Including 19 Oral Presentations at the 2025 International Society for Heart and Lung Transplantation Meeting - Business Wire
- 22 days ago - CareDx Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 5 weeks ago - CareDx to Report First Quarter 2025 Financial Results - Business Wire
- 6 weeks ago - CAREDX INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of CareDx, Inc. - CDNA - Business Wire